Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Worldwide comparison of ovarian cancer survival: Histological group and stage at diagnosis (CONCORD-2).

Matz M, Coleman MP, Carreira H, Salmerón D, Chirlaque MD, Allemani C; CONCORD Working Group.

Gynecol Oncol. 2017 Feb;144(2):396-404. doi: 10.1016/j.ygyno.2016.11.019. Epub 2016 Dec 2. Erratum in: Gynecol Oncol. 2017 Dec;147(3):725.

PMID:
27919574
2.

The histology of ovarian cancer: worldwide distribution and implications for international survival comparisons (CONCORD-2).

Matz M, Coleman MP, Sant M, Chirlaque MD, Visser O, Gore M, Allemani C; & the CONCORD Working Group.

Gynecol Oncol. 2017 Feb;144(2):405-413. doi: 10.1016/j.ygyno.2016.10.019. Epub 2016 Dec 6. Erratum in: Gynecol Oncol. 2017 Dec;147(3):726.

PMID:
27931752
3.

Disparities in ovarian cancer survival in the United States (2001-2009): Findings from the CONCORD-2 study.

Stewart SL, Harewood R, Matz M, Rim SH, Sabatino SA, Ward KC, Weir HK.

Cancer. 2017 Dec 15;123 Suppl 24:5138-5159. doi: 10.1002/cncr.31027.

PMID:
29205312
4.

Italian cancer figures--Report 2015: The burden of rare cancers in Italy.

AIRTUM Working Group, Busco S, Buzzoni C, Mallone S, Trama A, Castaing M, Bella F, Amodio R, Bizzoco S, Cassetti T, Cirilli C, Cusimano R, De Angelis R, Fusco M, Gatta G, Gennaro V, Giacomin A, Giorgi Rossi P, Mangone L, Mannino S, Rossi S, Pierannunzio D, Tavilla A, Tognazzo S, Tumino R, Vicentini M, Vitale MF, Crocetti E, Dal Maso L.

Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035. Erratum in: Epidemiol Prev. 2016 Mar-Apr;40(2):83.

5.

Primary ovarian cancer at National Taiwan University Hospital: 1980-1989.

Chen CK, Chow SN, Chen RJ, Chen YP, Huang LC, Wang LI, Lin YH, Huang SC.

Int Surg. 1994 Jan-Mar;79(1):48-51.

PMID:
8063555
6.

Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.

Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, Bonaventure A, Valkov M, Johnson CJ, Estève J, Ogunbiyi OJ, Azevedo E Silva G, Chen WQ, Eser S, Engholm G, Stiller CA, Monnereau A, Woods RR, Visser O, Lim GH, Aitken J, Weir HK, Coleman MP; CONCORD Working Group.

Lancet. 2018 Mar 17;391(10125):1023-1075. doi: 10.1016/S0140-6736(17)33326-3. Epub 2018 Jan 31.

PMID:
29395269
7.

Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership.

Maringe C, Walters S, Butler J, Coleman MP, Hacker N, Hanna L, Mosgaard BJ, Nordin A, Rosen B, Engholm G, Gjerstorff ML, Hatcher J, Johannesen TB, McGahan CE, Meechan D, Middleton R, Tracey E, Turner D, Richards MA, Rachet B; ICBP Module 1 Working Group.

Gynecol Oncol. 2012 Oct;127(1):75-82. doi: 10.1016/j.ygyno.2012.06.033. Epub 2012 Jun 27.

PMID:
22750127
8.

Association of lymphadenectomy and survival in stage I ovarian cancer patients.

Chan JK, Munro EG, Cheung MK, Husain A, Teng NN, Berek JS, Osann K.

Obstet Gynecol. 2007 Jan;109(1):12-9.

PMID:
17197582
9.

Patterns and progress in ovarian cancer over 14 years.

Chan JK, Cheung MK, Husain A, Teng NN, West D, Whittemore AS, Berek JS, Osann K.

Obstet Gynecol. 2006 Sep;108(3 Pt 1):521-8.

PMID:
16946210
10.

Italian cancer figures, report 2012: Cancer in children and adolescents.

AIRTUM Working Group; CCM; AIEOP Working Group.

Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225. English, Italian.

11.

Ovarian cancer in France: trends in incidence, mortality and survival, 1980-2012.

Trétarre B, Molinié F, Woronoff AS, Bossard N, Bessaoud F, Marrer E, Grosclaude P, Guizard AV, Delafosse P, Bara S, Velten M, Lapôtre-Ledoux B, Ligier K, Léone N, Arveux P, Uhry Z.

Gynecol Oncol. 2015 Nov;139(2):324-9. doi: 10.1016/j.ygyno.2015.09.013. Epub 2015 Sep 14.

PMID:
26383829
12.

Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women.

Zhang M, Cheung MK, Shin JY, Kapp DS, Husain A, Teng NN, Berek JS, Osann K, Chan JK.

Gynecol Oncol. 2007 Feb;104(2):396-400. Epub 2006 Oct 9.

PMID:
17030354
13.

Survival of ovarian cancer patients in Denmark: excess mortality risk analysis of five-year relative survival in the period 1978-2002.

Hannibal CG, Cortes R, Engholm G, Kjaer SK.

Acta Obstet Gynecol Scand. 2008;87(12):1353-60. doi: 10.1080/00016340802483000.

PMID:
18951210
14.

Factors Affecting Short-term Mortality in Women With Ovarian, Tubal, or Primary Peritoneal Cancer: Population-Based Cohort Analysis of English National Cancer Registration Data.

Barclay M, Gildea C, Poole J, Hirschowitz L, Menon U, Nordin A.

Int J Gynecol Cancer. 2016 Jan;26(1):56-65. doi: 10.1097/IGC.0000000000000562.

PMID:
26509852
15.

Intraoperative frozen section analysis for the diagnosis of early stage ovarian cancer in suspicious pelvic masses.

Ratnavelu ND, Brown AP, Mallett S, Scholten RJ, Patel A, Founta C, Galaal K, Cross P, Naik R.

Cochrane Database Syst Rev. 2016 Mar 1;3:CD010360. doi: 10.1002/14651858.CD010360.pub2. Review.

PMID:
26930463
16.

Survival for ovarian cancer in Europe: the across-country variation did not shrink in the past decade.

Oberaigner W, Minicozzi P, Bielska-Lasota M, Allemani C, de Angelis R, Mangone L, Sant M; Eurocare Working Group.

Acta Oncol. 2012 Apr;51(4):441-53. doi: 10.3109/0284186X.2011.653437. Epub 2012 Feb 7.

PMID:
22313338
17.
18.

Adjuvant (post-surgery) chemotherapy for early stage epithelial ovarian cancer.

Lawrie TA, Winter-Roach BA, Heus P, Kitchener HC.

Cochrane Database Syst Rev. 2015 Dec 17;(12):CD004706. doi: 10.1002/14651858.CD004706.pub5. Review.

PMID:
26676202
19.

Optimal primary surgical treatment for advanced epithelial ovarian cancer.

Elattar A, Bryant A, Winter-Roach BA, Hatem M, Naik R.

Cochrane Database Syst Rev. 2011 Aug 10;(8):CD007565. doi: 10.1002/14651858.CD007565.pub2. Review.

PMID:
21833960
20.

Reasons for improved survival from ovarian cancer in New South Wales, Australia, between 1980 and 2003: implications for cancer control.

Tracey EA, Roder DM, Francis J, Zorbas HM, Hacker NF, Bishop JF.

Int J Gynecol Cancer. 2009 May;19(4):591-9. doi: 10.1111/IGC.0b013e3181a3a436.

PMID:
19509555

Supplemental Content

Support Center